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THALAMIC GLUTAMATE LEVELS PREDICT CORTICAL RESPONSE DURING 
EXECUTIVE FUNCTIONING IN SUBJECTS AT HIGH RISK FOR PSYCHOSIS 
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ABSTRACT 
Context: Alterations in glutamatergic neurotransmission and cerebral cortical dysfunction are thought to be 
central to the pathophysiology of psychosis, but the relationship between these two factors is unclear. 
Objective: To investigate the relationship between brain glutamate and cortical response during executive 
functioning in people at high risk for psychosis (with an “at risk mental state”; ARMS). 
Design: Subjects were studied using fMRI while performing a verbal fluency task, and with 1-H Magnetic 
Resonance Spectroscopy (1H-MRS) to measure brain regional glutamate levels. 
Patients and other participants: Forty-one subjects participated in the study: twenty-four ARMS subjects 
and seventeen healthy volunteers.  
Main outcome measures: Regional brain activation (BOLD response), levels of glutamate in the anterior 
cingulate, left thalamus and left hippocampus, and psychopathology ratings at the time of scanning. 
Results: During the verbal fluency task, ARMS subjects showed greater activation than controls in the 
middle frontal gyrus bilaterally. Thalamic glutamate levels were lower in the ARMS group than in controls. 
Within the ARMS sample, activation in the right dorsolateral prefrontal and left orbitofrontal cortex were 
negatively associated with thalamic glutamate levels, but positively associated with activation in the right 
hippocampus and in the temporal cortex bilaterally. There was also a significant group difference in the 
relationship between cortical activation and thalamic glutamate levels, with controls showing correlations in 
the opposite direction to those in the ARMS group in the prefrontal cortex, and in the right hippocampus and 
superior temporal gyrus.  
Conclusions: Altered prefrontal, hippocampal and temporal function in people with an ARMS is related to a 
reduction in thalamic glutamate levels, and this relationship is different from that in healthy controls. 
INTRODUCTION 
 
Cognitive deficits are a robust feature of schizophrenia, and a major contributor to the substantial functional 
disability associated with the disorder. Compared to controls, patients with schizophrenia show impaired 
behavioural performance on tasks that engage executive functions1, such as verbal fluency paradigms, and 
neuroimaging studies have shown that they differentially engage the prefrontal areas that normally mediate 
these processes during such tasks 2-5. Recent studies have reported that qualitatively similar impairments in 
behavioural performance and alterations in prefrontal activation are also evident in subjects who have 
prodromal symptoms of psychosis, but are not frankly psychotic 6-8. The prodromal symptoms of psychosis 
can be identified using standardized, structured assessments, based on a combination of clinical criteria: the 
presence of attenuated psychotic symptoms, or a family history of psychosis in connection with deterioration 
in social functioning, or a self-limiting psychotic episode which lasted less than one week 9. Individuals 
meeting these criteria have an “At Risk Mental State” (ARMS) which is associated with a high risk of 
developing a psychotic disorder within two years 10.  
 
Functional magnetic resonance imaging (fMRI) studies of verbal fluency in the ARMS indicate that the level 
of activation in prefrontal cortex is intermediate between that in psychotic patients and that in controls11, 
independent of differences in task performance or potential effects of antipsychotic medication. The 
relationship between prefrontal cortical dysfunction in this context and the neurochemical changes associated 
with psychosis is unclear. Over the past two decades there has been growing interest in the role of glutamate, 
the main excitatory neurotransmitter in the brain, in the pathophysiology of psychosis. Experimental 
administration of ketamine, an uncompetitive N-Methyl-D-Aspartate receptor (NMDA) antagonist, in 
healthy volunteers can produce impairments on tasks of executive function 12, 13 and alterations in cortical 
activation during verbal fluency that are comparable to those seen in schizophrenia 14. Animal models of 
psychosis suggest that blockade of NMDA receptors can lead to increased cortical glutamate release 15, 16 and 
the loss of cortical neurons 17. These effects appear to be driven by NMDA receptor blockade in the thalamus 
rather a direct effect on NMDA receptors in the cortex 16, 18. Proton magnetic resonance spectroscopy (1H-
MRS) permits direct measurement of glutamate and glutamine (a marker of glutamate release) in living 
human subjects. Recent 1H-MRS studies have shown an increase in anterior cingulate levels of glutamine, 
following the acute administration of ketamine 19, closely resembling the previously reported findings in 
animals 15, 16. Abnormal anterior cingulate glutamine levels have also been reported in patients undergoing 
the first episode of schizophrenia 20. We recently found altered anterior cingulate glutamine levels in subjects 
with an ARMS, but the most striking finding in this group was a reduction in thalamic glutamate levels, 
which was associated with reductions in prefrontal, temporal and hippocampal grey matter volume in the 
same individuals21.  
 
The aim of the present study was to examine the relationship between the cortical response during a task of 
executive functioning and central glutamate levels in subjects with an ARMS. We selected this group 
because it is thought that glutamate dysfunction may be particularly important in the early stages of 
psychosis 20, 22, 23, and because individuals with an ARMS are usually treatment naïve, and antipsychotic 
medication may alter both cortical activation 24 and glutamate activity 25. We studied the same individuals 
using two different neuroimaging techniques: functional magnetic resonance imaging was used to assess 
cortical responses during a verbal fluency task, and 1H-MRS was used to measure regional glutamate levels. 
These techniques were applied to a sample of subjects with an ARMS and a demographically matching 
group of healthy volunteers. On the basis of previous studies, we predicted that, relative to controls, the 
ARMS group would show altered activation in prefrontal cortex 11, 26 while performing the verbal fluency 
task 27, and reduced glutamate levels in the thalamus 21. We then tested our main hypothesis: that within the 
ARMS group, the severity of the alteration in cortical function would be related to the change in thalamic 
glutamate levels. 
 
MATERIAL AND METHODS 
Subjects 
Individuals meeting criteria for the an At-Risk Mental State (ARMS) (n=24) were recruited from Outreach 
and Support in South London (OASIS) 28. The diagnosis was based on assessment by two experienced 
clinicians, using the Comprehensive Assessment for the ARMS (CAARMS) 9, as well as a consensus 
meeting with the clinical team. All subjects were antipsychotic naïve at the time of the scanning. Two 
subjects were receiving antidepressant medication. The subjects were representative of the local population 
of people presenting with an ARMS in terms of age, gender, ethnicity, and duration and intensity of 
symptoms 28. Subjects were excluded if there was a history of neurological disorder or they met DSM-IV 
criteria for a substance dependence or abuse disorder. Controls (n=17) were recruited from the same 
geographical area via advertisements in the local media. Control subjects had no history of psychiatric 
symptoms, substance dependence / abuse, medical illness or use of psychotropic medications and no family 
history of psychiatric illness. All subjects but one (an ARMS subject) were right-handed, as evaluated using 
the Lateral Preferences Inventory 29, and all were native speakers of English.  
Clinical measures 
Prior to scanning, all subjects were interviewed about their family and personal psychiatric history, current 
and past medication use. The severity of psychotic symptoms in the two groups was assessed at the time of 
scanning using the CAARMS 9 and the Positive and Negative Symptom Scale (PANSS) 30. Consumption of 
illicit substances, alcohol, tobacco and coffee/tea was evaluated using a  modified version of the Cannabis 
Experience Questionnaire (CEQ) 31. Affective symptoms were assessed with the Hamilton Depression and 
Anxiety Scales (HAM-D and HAM-A) 32. Premorbid intelligence was assessed using the National Adult 
Reading Test (NART) 33. Although individual differences in the personality dimensions of 
introversion/extroversion may affect brain function during cognitive activity 34 and glutamate levels 35 we did 
not measure these personality domains in the present study. The effect of group on demographic and clinical 
measures was tested using analyses of variance for parametric variables, and Mann-Whitney U tests were 
used to compare individuals with ARMS to controls for nonparametric variables after checking for equality 
of variance with the Levene test. 
fMRI scanning 
Image acquisition 
For each participant, T2*-weighted gradient-echo single-shot echo-planar images were acquired on a 1.5 
Tesla Signa (General Electric, Milwaukee) system at the Maudsley Hospital, London.  Images comprised of 
14 noncontiguous axial planes (7-mm thickness, slice skip: 1 mm) parallel to the anterior commissure-
posterior commissure line and were acquired with TE=40 msec, flip angle=70°, a matrix size of 64x64 pixels 
and a field of view of 200mm. Because the experimental paradigm required subjects to articulate a verbal 
response, we used a "clustered" acquisition sequence 36, 37. A clustered acquisition sequence capitalizes on 
the delay of the haemodynamic response, which reaches its peak about 3000–5000 msec after stimulus onset 
38. A letter cue was presented for 750 msec and an overt verbal response could be made over a silent period 
of 2900 msec; an image was then acquired over 1100 msec resulting in a total repetition time (TR) of 4000 
msec. 
Verbal Fluency task (VF). Subjects were required to overtly articulate a word beginning with a visually 
presented letter. The stimuli, each subtending an angle of 5°, were presented in white on a black screen, 
viewed through a mirror. Cognitive load was modulated with 2 levels of task difficulty: ‘easy’ and ‘hard’ 
conditions using letters that differed with respect to the ease with which volunteers can usually generate 
words in response to them. The ‘easy’ condition involved the letters L, T, C, P, S; the ‘hard’ condition O, N, 
E, F, G 3. Incorrect responses were defined as words that were proper names, repetitions or grammatical 
variations of the previous word, and 'pass' responses. Letters were presented in 28 second (s) blocks of 7 
stimuli at 4 s intervals. The control condition of word repetition comprised 28 s blocks of 7 presentations of 
the word ‘rest’ at 4 s intervals, which subjects were required to read aloud. Five blocks of each condition 
(Hard/Easy/Repetition) were presented in random order. Verbal responses were recorded via a MRI 
compatible microphone using Cool Edit 2000 software (Syntrillium Software Corporation). To ensure that 
subjects heard their responses clearly, their speech was transmitted by a MRI compatible microphone, 
amplified by a computer sound card, and relayed back through an acoustic MRI sound system (Ward Ray, 
Hampton Court, UK) and noise insulated, stereo headphones at a volume of 91 + 2 dB. The effect of group 
on response accuracy during scanning was tested using an ANOVA. 
Analysis of fMRI data 
Functional MRI data were analyzed using Statistical Parametric Mapping (SPM5; Wellcome Department of 
Cognitive Neurology, London, United Kingdom) running in MATLAB7.1. All volumes were realigned to 
the first volume, corrected for motion, mean adjusted by proportional scaling, normalized into standard 
stereotactic space (template provided by the Montreal Neurological Institute) and smoothed using a 6mm 
full-width-at half-maximum Gaussian kernel. The time series were high pass filtered to eliminate low-
frequency components (filter width 128 s). In the first level analysis the onset times (in seconds) for each 
trial was convolved with a canonical haemodynamic response function. Because no significant effect of 
cognitive load on regional activation was observed, each task condition (easy, hard) was then contrasted 
against the baseline condition (rest) in each subject. Because group differences in task performance could 
contribute to group differences in activation, the analysis was restricted to images associated with correct 
responses. To test the hypothesis that there were between-group differences, we performed a second level 
analysis comparing the activation during verbal fluency, independent of task demand (easy and hard word 
generation combined versus word repetition) between the two groups (controls and ARMS), using an 
ANOVA between-subjects test. As we were testing an a-priori hypothesis regarding group effects in the 
frontal lobe11, 39, we used a frontal lobe mask generated by WFU Pickatlas (http://www.fmri.wfubmc.edu/) 40 
for second-level group contrasts. The mask included frontal regions corresponding to Brodmann areas (BA) 
4, 6, 8, 9, 46, 10, 11, 47, 45, 44, 32, and 24. The whole brain voxel-wise threshold was set at p< .05 [FWE-
corrected]27.  
 
1H-MRS scanning 
Volumetric MRI acquisition 
The fMRI and MRS scans in each subject were performed as close together as was practically possible. In 
many subjects both scans were performed in the same week, but restrictions on the availability of scanning 
slots meant that this was not always possible. All MRS scanning took place on a General Electric 
(Milwaukee, USA) 3T MR system at the Centre for Neuroimaging Sciences. After positioning the subject in 
the scanner with earplugs and a foam rest under their knees, they were scanned with an initial three-plane 
localiser scan. This was used to measure the interhemispheric angle and the AC-PC line (the line passing 
through the upper part of the anterior commisure and the lower part of the posterior commisure). This was 
followed by an axial 2D T2 weighted Fast Spin Echo scan and an axial fast FLAIR (Fluid Attenuated 
Inversion Recovery) scan, both prescribed parallel to the AC-PC line, which together were used for visual 
assessment to exclude any gross structural abnormality. These were followed by a whole brain 3D coronal 
IR-SPGR (inversion recovery prepared spoiled gradient echo) scan, prescribed from the midline sagittal 
localiser images, giving isotropic 1.1mm voxel size (TE = 2.82ms; TR = 6.96ms; TI = 450ms; excitation flip 
angle = 20º) in a scan time of approximately 6 minutes. The IR-SPGR scans were used for localisation of the 
spectroscopy ROIs, and were subsequently segmented into grey matter, white matter and CSF using SPM2 to 
allow correction of the spectroscopy results for partial volume CSF contamination.  
1H-MRS protocol 
MRS spectra (PRESS - Point RESolved Spectroscopy - TE=30ms, TR=3000ms, 96 averages) were acquired 
in the anterior cingulate, left hippocampus and left thalamus. An automated shimming and water suppression 
method was used41, and the auto-prescan was performed twice prior to each scan. The centre of the 20mm x 
20mm x 20mm anterior cingulate Region of Interest (ROI) was placed 13mm above the anterior section of 
the Genu of Corpus Callosum at 90o to the AC-PC line (Figure 1). A 20mm x 20mm x 15mm (right-left, 
anterior-posterior, superior-inferior) left hippocampal voxel was prescribed from the coronal IR-SPGR 
(Figure 1). A 15mm x 20mm x 20mm (right-left, anterior-posterior, superior-inferior) left thalamic voxel was 
defined at the point in the coronal slices where the thalamus was widest, using sagittal and coronal views to 
ensure that the voxel was clear of CSF contamination (Figure 1). For each metabolite spectrum, 16 
unsuppressed water reference lines were also acquired as part of the standard PROBE acquisition (GE 
medical systems). We aimed for a maximum linewidth (FWHM) of the water peak at prescan of 7Hz for the 
anterior cingulate voxel, 10 Hz for the  thalamus, and 11 Hz for the hippocampus. After the subject left the 
scanner, each scanning session concluded with the collection of a PRESS spectrum from a phantom 
containing standard concentrations of brain metabolites to provide calibration data for the LCModel 
program. 
*** FIGURE 1 ABOUT HERE *** 
1H-MRS quantification 
All spectra were analysed using LCModel version 6.1-4F42. The raw spectral data were read into LCMgui, 
the graphical user interface for LCModel, which automatically combined the data from the eight-channel coil 
with a weighted coherent average over the eight receive channels using the intensity of the first point of the 
Free Induction Decay of the unsuppressed water reference from each coil.  A standard basis set of 16 
metabolites (L-alanine, aspartate, creatine, phosphocreatine, GABA, glucose, glutamine, glutamate, 
glycerophosphocholine, glycine, myo-inositol, L-lactate, N-acetylaspartate, N-acetylaspartylglutamate, 
phosphocholine, taurine), included as part of LCModel and acquired with the same field strength (3-T), 
localization sequence (PRESS), and echo time (30 msec) as our study was used. Model metabolites and 
concentrations employed in the basis set are fully detailed in the LCModel manual (http://s-provencher-
.com/pages/lcm-manual.shtml). The brain tissue content in the region corresponding to each ROI was 
determined through matching its location from the 1H-MRS file headers with the same region in the 
segmented IR-SPGR images. Water-scaled glutamate values were divided by the brain tissue (gray plus 
white matter) content of the voxel in each subject (CSF-corrected). Poorly fitted metabolite peaks (Cramer-
Rao minimum variance bounds of more than 20% reported by LCModel) were excluded from further 
analysis. 
 
Integration of 1H-MRS and fMRI data 
The relationship between the BOLD response during the VF task and glutamate levels was investigated by 
entering the glutamate measures as covariates in the independent sample sample t-test analysis of fMRI data. 
Glutamate-BOLD response interactions were assessed using whole brain regressions, conducted separately 
in ARMS and controls. In a second step, we explored the group by BOLD by glutamate interaction by 
modelling these factors in a different SPM design matrix. For all these contrasts whole brain voxel-wise 
threshold was set at p< .05 FWE-corrected. Post-hoc analyses were performed to evaluate the strength of 
these associations by extracting the beta values and testing them in a regression model in SPSS. Cook’s 
distance test was used to assess the effect of potential outliers on the above correlations. 
RESULTS 
Clinical characteristics of the sample 
Control and ARMS individuals did not differ in age (ARMS mean=26.6 [5] years, controls mean [SD]=25.5 
[3.6] years, t=1.490, p=0.146), estimated premorbid IQ (control mean [SD] =102.6 [9.2], ARMS mean 
[SD]=101.7 [12.3]; t=1.774, p=0.085) or gender (ARMS females n= 1, control females n= 7, X2=1.502, 
p=0.220), but controls had a significantly higher level of education than ARMS individuals (X2=0.049). 
There were no significant group differences in substance or alcohol use (p>0.05). ARMS subjects had higher 
levels of prodromal, psychotic, anxiety and depressive symptoms than controls, as measured using the 
CAARMS (thought disorders severity, t=7.789, p<0.001; perceptual disorders severity, t=3.377, p=0.002; 
speech disorders severity, t=2.194, p=0.035), PANSS (ARMS mean positive [SD]=12.67 [3.67], control 
mean positive [SD]=7.35 [1.01], t=4.667, p<0.001; ARMS mean negative [SD]=8.95 [2.71], control mean 
negative [SD]=7.07 [0.26], t=2.583, p=0.014; ARMS mean general [SD]=21.5 [4.2], control mean general 
[SD]=16.5 [0.77], t=4.399, p<0.001), HAM-A (ARMS mean [SD]=11.29 [3.44], control mean [SD]= 1.70 
[0.75], t=3.308, p=0.002) and HAM-D (ARMS mean [SD]=8.83 [3.14], control mean [SD]=0.71 [0.32], 
t=3.686, p=0.001), respectively. No significant correlations between glutamate levels or regional activation 
and psychotic, anxious or depressive symptoms were elicited. We did not try to subdivide the ARMS sample 
according to whether they developed psychosis subsequent to scanning, as the sample is still undergoing 
clinical follow up. At least two years follow up is needed to determine which individuals will become 
psychotic43. 
 
MRS results 
1H-MRS spectra quality were good in left thalamus and in anterior cingulate, with a mean (± SD) signal-to-
noise ratio reported by LCModel of 19 (± 4) and 19 (± 6) respectively, and of reasonable quality in left 
hippocampus with a mean (± SD) signal-to-noise ratio of 12 (3). Linewidths reported by LCModel followed 
a similar pattern with mean (± SD) of 5.3 (± 1.8) Hz in anterior cingulate, 6.6 (± 1.4) Hz in left thalamus, and 
8.9 (± 3.1) Hz in left hippocampus. There were no significant differences in spectral quality between control 
and ARMS subjects. ARMS subjects had lower glutamate levels (t=2.727, p=0.009) in left thalamus than 
controls. There was also a trend towards lower glutamate levels in the ARMS group than in controls in the 
left hippocampus (t=1.937, p=0.063). There were no significant group differences in glutamate levels in the 
anterior cingulate gyrus (p>0.05). 
 
 
 
 
Verbal fluency task 
Performance 
There was no significant difference in the accuracy of responses during the verbal fluency task between the 
ARMS and control groups  (p=0.109).  
Regional activation 
Main effect of task 
Across all subjects, word generation relative to word repetition was associated with activation in several 
regions of the cerebral cortex, with a significant lateralization effect on the left. Brain areas activated by the 
task included the inferior frontal gyrus bilaterally, and the left insula, superior frontal gyrus, and anterior 
cingulate gyrus (p<0.05). There was also subcortical activation in the left putamen and globus pallidus 
(Table Is and Figure 1s; see supplementary materials)(p<0.05).   
Main effect of group 
The ARMS group showed greater activation than controls in the middle frontal gyrus bilaterally (Table Is 
and Figure 2)(p<0.05). Conversely, no brain areas showed greater activation in the control group than the 
ARMS group.  
***FIGURE 2 ABOUT HERE*** 
 
Correlation between 1H-MRS and fMRI  
Thalamus 
Within-group correlations 
No significant correlations between cortical activation during verbal fluency and thalamic glutamate levels 
were observed in healthy controls. However, in the ARMS sample, thalamic glutamate levels were 
negatively associated with activation in the right dorsolateral prefrontal cortex (right middle frontal gyrus; 
R=0.784, R2=0.614, p<0.001) and the left orbitofrontal cortex (left middle frontal gyrus; R=0.602, 
R2=0.362, p=0.03), but positively associated with activation in the temporal cortex bilaterally (right superior 
temporal gyrus; R=0.801, R2=0.642, p<0.001; left middle temporal gyrus, R=0.465, R2=0.216, p=0.034) and 
in the right hippocampus (R=0.605, R2=0.366, p=0.04), but (Figure 3, Table I).  
Differences between groups 
There were significant interactions between these findings and group (p<0.05). In the prefrontal cortex 
bilaterally (left middle frontal and right superior frontal gyri), thalamic glutamate levels were negatively 
associated with activation in the ARMS, but positively associated with activation in controls (Figure 4, Table 
I). Conversely, thalamic glutamate was positively correlated with brain activation in the right hippocampus 
and superior temporal gyrus in the ARMS group, but negatively correlated in the control group.  
*** FIGURE 3 ABOUT HERE *** 
*** TABLE I ABOUT HERE *** 
*** FIGURE 4 ABOUT HERE *** 
Hippocampus and Anterior cingulate 
No significant correlations between cortical response during verbal fluency and glutamate levels in either the 
hippocampus or anterior cingulate cortex were observed in ARMS or in healthy controls, and there were no 
significant group by glutamate by cortical activation interactions. 
 
DISCUSSION 
To our knowledge this is the first study to explore the relationship between glutamate levels and cortical 
activation in relation to psychosis in human subjects. Consistent with data from previous investigations 21, 44, 
thalamic glutamate level was lower in the ARMS than in the controls, and ARMS subjects showed an 
increased frontal activation during the verbal fluency task 27. Within the ARMS sample, the glutamate level 
in the thalamus was positively associated with activation in the temporal cortex and hippocampus, but 
negatively associated with activation in the prefrontal cortex. Moreover, significant interactions between 
these findings and group were detected in the prefrontal and temporal cortex and in the hippocampus, 
indicating that the relationship between activation and glutamate levels was different in ARMS subjects and 
controls. 
In keeping with previous studies in healthy controls 39 and in patients with schizophrenia 45, our verbal 
fluency task preferentially activated the left prefrontal cortex, and this region was differentially activated in 
ARMS subjects and controls, with a greater BOLD response bilaterally in the former group. These 
differences in activation were evident in medication-naïve subjects24, in the context of similar levels of task 
performance. Moreover, the analysis was restricted to images associated with correct responses. The findings 
may thus reflect a true difference at the neurophysiological level, as opposed to a non-specific effect of 
differential task performance. Greater engagement of prefrontal cortex in clinical subjects has been 
interpreted as a manifestation of inefficient prefrontal processing46, and may underlie the behavioural 
impairment on executive functions that has consistently been observed in neuropsychological studies in 
ARMS subjects47, 48. Our fMRI findings are consistent with evidence that grey matter volume in prefrontal 
regions is also abnormal in the ARMS 49-51, as well as in first episode psychosis 52 and in chronic 
schizophrenia 53. 
The finding of reduced glutamate levels in the thalamus in ARMS subjects replicates a previous finding in a 
larger overlapping sample21, which contained some of the present ARMS group. It is not attributable to an 
effect of antipsychotic medication, as most of the ARMS subjects were medication naïve, nor to an effect of 
chronic illness, as none of these subjects had ever been frankly psychotic. Our main finding was that the 
relationship between thalamic glutamate levels and neuronal activation differed between the ARMS and 
control groups, particularly in the prefrontal and lateral temporal cortices and in the hippocampus. In the 
lateral temporal and hippocampal regions, the different relationship between thalamic glutamate levels and 
neuronal activation could be detected in the absence of different brain activation suggesting that, in these 
regions, alterations in glutamate levels may occur independently of cortical dysfunction. 
These findings taken together are consistent with evidence that administration of ketamine, an uncompetitive 
NMDA receptor antagonist, modulates activation during verbal fluency and resting state activity in these 
regions in healthy volunteers 14, 54, 55. Furthermore, we have previously shown that the level of thalamic 
glutamate in the ARMS is also correlated with gray matter volume in the prefrontal, temporal polar and 
medial temporal cortex 21. A study that combined 1H-MRS and MRI in schizophrenia found that there was a 
longitudinal reduction in thalamic glutamine (a precursor of glutamate) levels that was associated with a 
progressive reduction in temporal gray matter volume56. The prefrontal, temporal polar and hippocampal 
cortex have been widely implicated in the pathogenesis of psychotic disorders 50, and the present findings 
suggest that perturbed subcortical glutamate levels may contribute to alterations in the function of these 
areas. The localisation of the correlations with glutamate to the prefrontal, temporal and hippocampal cortex 
is also consistent with post mortem evidence that these regions are sites of glutamatergic abnormalities in 
schizophrenia 57.  
The thalamus plays a key role in cognitive functioning, and prefrontal-thalamic interactions mediate the state 
of consciousness, the sleep-wake cycle, and executive functions 58, including those engaged during verbal 
fluency tasks59. A recent study employing simultaneous EEG recordings from deep brain structures and the 
scalp showed that the human thalamus systematically reacts to language analysis in coordination with 
cortical regions 60. Neuropathological and in vivo imaging studies in schizophrenia have identified several 
structural and functional abnormalities in the thalamus 61, and these changes have been related to cognitive 
impairments 62 and symptomatology in psychosis 63.  It is thus plausible that abnormalities in thalamic 
neurotransmission could contribute to the development of psychosis. 
 
The relationship between thalamic glutamate levels and cortical activation during verbal fluency in the 
ARMS sample was significantly different to that in controls. In the ARMS subjects, thalamic glutamate 
levels were negatively associated with the prefrontal cortical response, whereas the correlation was positive 
in controls, although it was not statistically significant. The negative correlation between frontal activation 
and thalamic glutamate levels within the ARMS group suggests that the greater the neurophysiological 
abnormality in the frontal cortex, the greater the neurochemical abnormality in the thalamus. Similarly, the 
positive correlations with activation in the right hippocampus and superior temporal gyrus in the ARMS 
were absent in controls, who showed a tendency for correlations in a negative direction. Interestingly, there 
were no interactions in those areas with normal glutamate values (hippocampus and anterior cingulate). This 
is consistent with the notion that the group differences in the correlations between activation and thalamic 
glutamate may have been a function of the group difference in glutamate values in the thalamus. 
The correlation coefficients in the ARMS group were strong (ranging from 0.46 to 0.8), suggesting that there 
is a close relationship between the alterations in glutamate levels and in cortical function in people with an 
enhanced risk of psychosis. The opposite direction of the associations between glutamate and activation in 
the prefrontal and temporal cortices may reflect the opposite direction of the BOLD responses in the 
respective regions during verbal fluency tasks, with activation in prefrontal areas, but deactivation in 
temporal areas64. Nevertheless, regardless of the directions of the correlations, there were significant 
differences in the relationship between glutamate levels and cortical response in ARMS subjects compared to 
controls.  
 
The healthy brain may compensate for the potential effects of inter-subject variations in thalamic glutamate 
levels on cortical function, or vice versa. However, in the ARMS, the regulation of thalamic and / or cortical 
function may be compromised, such that variations in glutamate levels can directly affect cortical function. 
However, because it is not possible to determine the direction of causality from our data, it might equally 
reflect prefrontal dysfunction resulting in altered top-down influences on thalamic glutamate levels. While 
we observed a significant correlation between glutamate levels and cortical activation, there was no evidence 
of a correlation between glutamate levels and performance on the verbal fluency task (p>0.05). Task 
performance can be seen as an indirect measure of the underlying cortical physiology, and may be influenced 
by a range of additional factors. It is thus not surprising that we were able to detect a relationship between 
glutamate levels and cortical activation, but not with task performance. The latter might have been evident if 
there had been significant group differences in task performance, and if the study had been powered to detect 
differences at the behavioural, as opposed to the physiological level. 
 
About a third of subjects with an ARMS will subsequently develop psychosis, some will continue to 
experience prodromal symptoms but not become psychotic, while others will recover to the extent that they 
no longer meet criteria for the ARMS 65. Given the cross-sectional nature of the present study, it remains to 
be determined whether the observed glutamatergic and prefrontal alterations represent “state” risk factors, or 
are true “trait” vulnerability markers specifically linked to the later onset of psychosis. 44, 66. This issue will 
be addressed by follow up of the present sample to determine their long term clinical outcome. This entails 
clinical monitoring for at least 24 months post scanning (as most transitions to psychosis occur during this 
period43), and at present most of the sample are still undergoing follow up. Although we focused on 
glutamatergic abnormalities in the thalamus, pathways linking the thalamus and the cerebral cortex also 
involve GABAergic and dopaminergic neurotransmission 63, and GABA and dopamine  may also play a 
crucial role in the pathophysiology of psychosis  67 27.  
CONCLUSION 
 
In subjects with prodromal signs of psychosis, altered prefrontal, temporal and hippocampal responses 
during verbal fluency were related to a reduction in thalamic glutamate levels. This relationship was not 
evident in controls, and may underlie the increased vulnerability to psychosis that is evident in the former 
group. 
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Figure 1. Figure 1. Location of voxel placement for proton MRS acquisition: left hippocampus 
(upper left), anterior cingulate (upper right), right thalamus (lower left). 
 
Figure 2. Between group differences in activation during the verbal fluency task. The ARMS group 
showed greater activation than controls (red clusters) in the right superior frontal gyrus and in the 
left middle frontal gyrus. The left side of the brain is shown on the left side of the figure. 
 
FIGURE 3. Correlations between thalamic glutamate levels and brain activation in ARMS subjects 
during verbal fluency (positive correlations are shown in red and negative correlations in blue). 
Positive correlations were evident in the right superior temporal gyrus, hippocampus and in the left 
middle temporal gyrus. Negative correlations were evident in the middle frontal gyrus bilaterally.  
 
Figure 4. Between group interactions between thalamic glutamate and cortical responses during 
verbal fluency. In the prefrontal cortex bilaterally (plots on the left of the figure), thalamic 
glutamate levels were negatively associated with activation in the ARMS group, but there was no 
significant correlation in controls. In the right hippocampus and superior temporal gyrus (right of 
the figure), the correlation in the ARMS sample was negative, while that in the controls was again 
non significant. 
 
